Total Current Liabilities
Gilead Sciences Total Current Liabilities decreased by 3.9% to $11.81B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.6%, from $12.00B to $11.81B. Over 5 years (FY 2020 to FY 2025), Total Current Liabilities shows relatively stable performance with a 0.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A rising trend relative to current assets may indicate tightening liquidity or increased operational leverage.
Detailed definition
The sum of all financial obligations and debts that are due to be settled within one year or one operating cycle. This i...
Peer comparison
Used in the calculation of the Current Ratio and Quick Ratio to assess a firm's short-term financial health relative to industry peers.
total_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.21B | $10.25B | $11.61B | $8.56B | $9.22B | $10.42B | $11.24B | $10.53B | $13.96B | $11.95B | $11.28B | $13.02B | $10.78B | $11.73B | $12.00B | $12.34B | $11.19B | $12.30B | $11.81B |
| QoQ Change | — | +0.3% | +13.3% | -26.3% | +7.7% | +13.0% | +7.8% | -6.3% | +32.6% | -14.5% | -5.6% | +15.4% | -17.2% | +8.8% | +2.4% | +2.8% | -9.4% | +9.9% | -3.9% |
| YoY Change | — | — | — | — | -9.7% | +1.7% | -3.2% | +23.0% | +51.5% | +14.6% | +0.4% | +23.6% | -22.8% | -1.8% | +6.4% | -5.2% | +3.8% | +4.9% | -1.6% |
Total Current Liabilities at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's total current liabilities?
- Gilead Sciences (GILD) reported total current liabilities of $11.81B in Q4 2025.
- How has Gilead Sciences's total current liabilities changed year-over-year?
- Gilead Sciences's total current liabilities decreased by 1.6% year-over-year, from $12.00B to $11.81B.
- What is the long-term trend for Gilead Sciences's total current liabilities?
- Over 5 years (2020 to 2025), Gilead Sciences's total current liabilities has grown at a 0.7% compound annual growth rate (CAGR), from $11.40B to $11.81B.
- What does total current liabilities mean?
- The total amount of money the company owes to others that is due within one year.